NR2E3 and acute leukemia: Collectively our results quantify the control exerted by ATR on convergent nucleotide biosynthetic routes, and provide the rationale to co-target both signaling (ATR) and metabolic (RNR and dCK) mechanisms in acute leukemia for optimal therapeutic efficacy.